Turkish Language and Cross-cultural Adaptation of the Cumberland Ankle Instability Tool

NCT05977660 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2024-02-20

No results posted yet for this study

Summary

Cumberland Ankle Instability Tool (CAIT) is a valid patient-reported outcome measure (PROM) to determine the presence of ankle instability (AI) and assess its severity. The aim of current study is to adapt the CAIT into the Turkish language, test its psychometric properties and determine cut-off score in the Turkish population with AI compare to healthy counterparts. In order to evaluate the Turkish version of CAIT (CAIT-TR), data will obtaine from 200-250 participants with and without AI. Test-retest reliability, internal consistency, cut-off score, and ceiling and floor effects will evaluate.

Conditions

  • Ankle Injuries
  • Instability, Joint

Interventions

DIAGNOSTIC_TEST

Cumberland ankle instability tool for diagnose to determine ankle instability and its severity

CAIT is a Patient-reported measures of outcome (PROM) and it is very simple, reliable, and valid measurement tool that is used without comparing with the contralateral ankle, which consists of 9 questions and is scored between 0 and 30, developed by Hiller and her colleagues in 2006 to measure the severity of functional ankle instability. Low scores of the participants indicate poor ankle stability, while high scores indicate good ankle stability.

Sponsors & Collaborators

  • Eskisehir Technical University

    lead OTHER

Principal Investigators

  • Erdem Atalay, Md. Phd. · Department of Sport Medicine, Eskişehir Osmangazi University

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-29
Primary Completion
2023-09-10
Completion
2023-10-25

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05977660 on ClinicalTrials.gov